Guidance on anti-viral medications to treat COVID-19 infections

Estimated read time: 1 min read
Dr Ayesha Verrall made a media statement on Thursday 14 July 2022 announcing the widened eligibility criteria for patients who have COVID-19 infection.

This has created some concern amongst our members regarding the medicolegal risks associated with this.  Medical Protection has published this guidance which you may find helpful. 

MPS Guidance on anti-viral medications to treat COVID-19 infections